Nalaganje...
Dupilumab and COVID‐19: What should we expect?
Coronavirus disease 2019 (COVID‐19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. There are very limited data on the interference of immunomodulating drugs on the risk of infection and on the course of the disease. In...
Shranjeno v:
| izdano v: | Dermatol Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267436/ https://ncbi.nlm.nih.gov/pubmed/32362061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13502 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|